[The detection of microsatellite instability by ion-pair reversed-phase high performance liquid chromatography]. 2004

Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
Department of Molecular Biology, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, PR China.

OBJECTIVE To set up a sensitive and stable technique which has high throughout to detect the instability of microsatellite DNA. METHODS Genomic DNA extracted from the cancer tissues and their normal tissues were subjected to microsatellite instability(MSI) analysis on five of DNA markers in 115 sporadic colorectal cancers by means of PCR and ion-pair reversed-phase high performance liquid chromatography. Genomic DNA extracted from lymphocytes in blood of 20 normal persons were analysed and used as the standard control. RESULTS Seventeen (14.8%) MSI-H and 23(20.0%) MSI-L were found in 115 sporadic colorectal cancers. The rates of MSI in the young patients and old patients were much higher than that in the middle-age patients (P<0.05). And the rate of MSI in low differentiation group was also much higher than that in high or middle differentiation groups (P<0.05). CONCLUSIONS The method the authors developed is a sensitive and accurate technique to detect MSI and has a high throughput.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003123 Colorectal Neoplasms, Hereditary Nonpolyposis A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair (MMR) genes. It has been subdivided into Lynch syndrome I or site-specific colonic cancer, and LYNCH SYNDROME II which includes extracolonic cancer. Colon Cancer, Familial Nonpolyposis, Type 1,Colorectal Cancer, Hereditary Nonpolyposis, Type 1,Familial Nonpolyposis Colon Cancer Type 1,Hereditary Nonpolyposis Colorectal Cancer,Hereditary Nonpolyposis Colorectal Cancer Type 1,Hereditary Nonpolyposis Colorectal Neoplasms,Lynch Syndrome,Colon Cancer, Familial Nonpolyposis,Colorectal Cancer Hereditary Nonpolyposis,Familial Nonpolyposis Colon Cancer,Hereditary Nonpolyposis Colon Cancer,Lynch Cancer Family Syndrome I,Lynch Syndrome I,Syndrome, Lynch
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
February 2000, Analytical chemistry,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
January 2001, Nucleic acids research,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
November 1982, Clinical chemistry,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
January 1992, Journal of chromatography,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
June 1984, Journal of chromatography,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
May 1987, Journal of chromatography,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
September 2012, Talanta,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
March 1991, Journal of chromatography,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
January 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Xiao-rong Liu, and Ya-ping Wang, and Jun-ni Zhang, and Jin-tian Li, and Xiao-mei Zhang, and Ming Zhu, and Xiang-nian Shan
February 1979, Journal of chromatography,
Copied contents to your clipboard!